Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boufassa

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|February 24, 2001
Incidence of clinical lipodystrophy in HIV-infected patients treated during primary infectionC Goujard, F Boufassa, C Deveau, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 2, 2005
[Pregnancy termination between 12 and 14 weeks gestation: practices and early complications in comparison with termination between 8 and 12 weeks]F Bacle, F Boufassa, J Lambert, et al.
AIDS (London, England)|February 24, 2001
Cytomegalovirus seroconversion as a cofactor for progression to AIDSM Robain, F Boufassa, J B Hubert, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
The use of auxiliary events to improve the analysis of survival for HIV-infected patients: application to the French Prospective Multicenter Cohort (SEROCO)P Flandre, F Boufassa, L Gerard, et al.
Epidemiology and Infection|December 16, 2000
Is cytomegalovirus infection a co-factor in HIV-1 disease progression?M Robain, F Boufassa, J B Hubert, et al.
AIDS (London, England)|April 19, 2000
Sexual behavior changes and protease inhibitor therapy. SEROCO Study GroupM Miller, L Meyer, F Boufassa, et al.
AIDS (London, England)|January 1, 1996
High risk of HIV disease progression after infection through a sexual partner with AIDSN Carré, L Meyer, F Boufassa, et al.
The Journal of Infectious Diseases|May 1, 1995
Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study GroupF Boufassa, C Bachmeyer, N Carré, et al.
International Journal of Epidemiology|December 5, 1998
Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupN Carré, F Boufassa, J B Hubert, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 31, 2006
[Risk factors for incident cervical intraepithelial neoplasia (CIN) among HIV-infected women: a prospective study]S Fridmann, F Boufassa, I Cartier, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|February 24, 2001
Incidence of clinical lipodystrophy in HIV-infected patients treated during primary infectionC Goujard, F Boufassa, C Deveau, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 2, 2005
[Pregnancy termination between 12 and 14 weeks gestation: practices and early complications in comparison with termination between 8 and 12 weeks]F Bacle, F Boufassa, J Lambert, et al.
AIDS (London, England)|February 24, 2001
Cytomegalovirus seroconversion as a cofactor for progression to AIDSM Robain, F Boufassa, J B Hubert, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
The use of auxiliary events to improve the analysis of survival for HIV-infected patients: application to the French Prospective Multicenter Cohort (SEROCO)P Flandre, F Boufassa, L Gerard, et al.
Epidemiology and Infection|December 16, 2000
Is cytomegalovirus infection a co-factor in HIV-1 disease progression?M Robain, F Boufassa, J B Hubert, et al.
AIDS (London, England)|April 19, 2000
Sexual behavior changes and protease inhibitor therapy. SEROCO Study GroupM Miller, L Meyer, F Boufassa, et al.
AIDS (London, England)|January 1, 1996
High risk of HIV disease progression after infection through a sexual partner with AIDSN Carré, L Meyer, F Boufassa, et al.
The Journal of Infectious Diseases|May 1, 1995
Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study GroupF Boufassa, C Bachmeyer, N Carré, et al.
International Journal of Epidemiology|December 5, 1998
Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupN Carré, F Boufassa, J B Hubert, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 31, 2006
[Risk factors for incident cervical intraepithelial neoplasia (CIN) among HIV-infected women: a prospective study]S Fridmann, F Boufassa, I Cartier, et al.
Pageof 3